|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Elusys Therapeutics, Inc.
| | | Phone: | (973) 808-0222 | Fax: | (973) 808-0322 | Year Established: | 1998 | Main Contact: | Jeremy Middleton, BS, VP, Corporate Development | | Other Contacts: | Vera Wong, MBA, CPA, VP, Finance Robin Conrad, MS, VP, Regulatory Affairs James Porter, VP, Development and Manufacturing Elizabeth Posillico, PhD, President & CEO Jeremy Middleton, VP, Corporate Development
| | Company Description | Elusys Therapeutics, a private company based in Pine Brook, NJ, is focused on the development of antibody therapeutics for the treatment of infectious disease. Elusys has received over $240 million in development grants and contracts from the U.S. Department of Defense (DoD), National Institutes of Health (NIH) and BARDA. In November 2015, Elusys was awarded a $45M delivery order from the U.S. government to produce ANTHIM for the U.S. Strategic National Stockpile (SNS), the U.S. government’s repository of critical medical supplies for public health emergency preparedness. Current investors include Essex Woodlands Health Ventures LLC, Invesco Private Capital, Crescendo Ventures, MedImmune Ventures and Pfizer. | |
|
|
|
|
|